I get the riposte. That’s fine.
I’m seeing milestones ticked off, customers investing and now a wholesale shift from a science led to commercial led team.
From here things can start to happen and yes 60c is cheap. I’d take 60c now tbh if it was offered given the current milestones but another years progress would need a multiple on that.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - 31 March 2023
I get the riposte. That’s fine. I’m seeing milestones ticked...
Featured News
Add BGT (ASX) to my watchlist
|
|||||
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.866M |
Open | High | Low | Value | Volume |
4.9¢ | 5.0¢ | 4.9¢ | $2.454K | 49.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 160114 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 82097 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 160114 | 0.049 |
1 | 113070 | 0.048 |
1 | 28400 | 0.046 |
1 | 40860 | 0.044 |
1 | 200000 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 82097 | 1 |
0.053 | 10103 | 1 |
0.057 | 34160 | 1 |
0.058 | 57400 | 1 |
0.068 | 10000 | 1 |
Last trade - 13.15pm 03/07/2024 (20 minute delay) ? |
Featured News
BGT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online